Chemaly, R. F., Dadwal, S. S., Bergeron, A., Ljungman, P., Kim, Y., Cheng, G., Pipavath, S. N., Limaye, A. P., Blanchard, E., Winston, D. J., Stiff, P. J., Zuckerman, T., Lachance, S., Rahav, G., Small, C. B., Mullane, K. M., Patron, R. L., Lee, D., Hirsch, H. H., Waghmare, A., McKevitt, M., Jordan, R., Guo, Y., German, P., Porter, D. P., Gossage, D. L., Watkins, T. R., Marty, F. M., Chien, J. W., & Boeckh, M. (2020). a Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients. Clinical infectious diseases, 71, 2777–2786. http://access.bl.uk/ark:/81055/vdc_100121989274.0x000048